Lars Hagenfeldt

7.7k total citations · 1 hit paper
165 papers, 6.1k citations indexed

About

Lars Hagenfeldt is a scholar working on Clinical Biochemistry, Molecular Biology and Physiology. According to data from OpenAlex, Lars Hagenfeldt has authored 165 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Clinical Biochemistry, 46 papers in Molecular Biology and 46 papers in Physiology. Recurrent topics in Lars Hagenfeldt's work include Metabolism and Genetic Disorders (51 papers), Muscle metabolism and nutrition (41 papers) and Diet and metabolism studies (34 papers). Lars Hagenfeldt is often cited by papers focused on Metabolism and Genetic Disorders (51 papers), Muscle metabolism and nutrition (41 papers) and Diet and metabolism studies (34 papers). Lars Hagenfeldt collaborates with scholars based in Sweden, United States and France. Lars Hagenfeldt's co-authors include J. Wahren, Philip Felig, John Wahren, G. Ahlborg, Agne Larsson, Rosa Hendler, Ulrika von Döbeln, Nikolaos Venizelos, L. Bjerkenstedt and S. Eriksson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Lars Hagenfeldt

164 papers receiving 5.6k citations

Hit Papers

Substrate Turnover during Prolonged Exercise in Man 1974 2026 1991 2008 1974 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Hagenfeldt Sweden 42 2.3k 1.9k 1.8k 1.3k 884 165 6.1k
P. B. Garland United Kingdom 11 3.3k 1.4× 1.2k 0.7× 2.3k 1.3× 562 0.4× 1.5k 1.7× 11 6.2k
Bjørn Quistorff Denmark 44 1.9k 0.8× 686 0.4× 1.9k 1.1× 360 0.3× 465 0.5× 181 6.3k
Dumitru Constantin‐Teodosiu United Kingdom 42 2.6k 1.1× 2.4k 1.3× 1.7k 1.0× 767 0.6× 221 0.3× 121 5.4k
John Wahren Sweden 52 5.5k 2.4× 3.0k 1.6× 2.8k 1.6× 1.2k 1.0× 3.1k 3.5× 143 11.9k
Renée Ventura‐Clapier France 59 3.1k 1.3× 1.3k 0.7× 5.8k 3.3× 479 0.4× 428 0.5× 195 10.4k
O E Owen United States 31 3.5k 1.5× 993 0.5× 844 0.5× 927 0.7× 1.0k 1.2× 47 5.1k
Christopher J. Lynch United States 52 3.3k 1.4× 1.5k 0.8× 4.8k 2.7× 421 0.3× 720 0.8× 146 8.7k
P J Randle United Kingdom 49 5.0k 2.1× 2.0k 1.1× 5.2k 3.0× 1.7k 1.3× 2.6k 2.9× 132 12.0k
J. Wahren Sweden 63 6.0k 2.6× 3.2k 1.7× 4.1k 2.3× 1.1k 0.8× 3.0k 3.4× 203 13.4k
Joaquı́n Arenas Spain 48 1.5k 0.6× 633 0.3× 4.7k 2.7× 1.9k 1.5× 479 0.5× 307 8.9k

Countries citing papers authored by Lars Hagenfeldt

Since Specialization
Citations

This map shows the geographic impact of Lars Hagenfeldt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Hagenfeldt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Hagenfeldt more than expected).

Fields of papers citing papers by Lars Hagenfeldt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Hagenfeldt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Hagenfeldt. The network helps show where Lars Hagenfeldt may publish in the future.

Co-authorship network of co-authors of Lars Hagenfeldt

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Hagenfeldt. A scholar is included among the top collaborators of Lars Hagenfeldt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Hagenfeldt. Lars Hagenfeldt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dragomir, Anca, Lena Hjelte, Lars Hagenfeldt, & Godfried M. Roomans. (2004). Heparin can improve the viability of transfected cystic fibrosis cell lines in vitro. Life Sciences. 75(18). 2203–2216. 4 indexed citations
2.
Fugelseth, Drude, et al.. (2001). Patent ductus venosus does not lead to alimentary galactosaemia in preterm infants. Acta Paediatrica. 90(2). 192–195. 5 indexed citations
3.
Venizelos, Nikolaos, Ulrika von Döbeln, & Lars Hagenfeldt. (1998). Fatty acid oxidation in fibroblasts from patients with defects in β‐oxidation and in the respiratory chain. Journal of Inherited Metabolic Disease. 21(4). 409–415. 23 indexed citations
4.
Hagenfeldt, Lars, et al.. (1990). 3-hydroxydicarboxylic aciduria—a fatty acid oxidation defect with severe prognosis. The Journal of Pediatrics. 116(3). 387–392. 60 indexed citations
5.
Svensson, Elisabeth, Björn Andersson, & Lars Hagenfeldt. (1990). Two mutations within the coding sequence of the phenylalanine hydroxylase gene. Human Genetics. 85(3). 300–4. 21 indexed citations
6.
Hagenfeldt, Lars, Gabriel Oxenstierna, Gunnel Alfredsson, et al.. (1988). A twin study of amino acid concentrations in cerebrospinal fluid. Journal of Psychiatric Research. 22(1). 51–56. 5 indexed citations
7.
Persson, Elisabeth, Jörgen Nordenström, Lars Hagenfeldt, & Peter Nilsson‐Ehle. (1987). Plasma lipolytic activity after subcutaneous administration of heparin and a low molecular weight heparin fragment. Thrombosis Research. 46(5). 697–704. 15 indexed citations
9.
Holst, Hans von & Lars Hagenfeldt. (1985). Increased levels of amino acids in human lumbar and central cerebrospinal fluid after subarachnoid haemorrhage. Acta Neurochirurgica. 78(1-2). 46–56. 11 indexed citations
10.
Alm, Jessica J., Lars Hagenfeldt, Agne Larsson, & Kristina Lundberg. (1984). Incidence of congenital hypothyroidism: retrospective study of neonatal laboratory screening versus clinical symptoms as indicators leading to diagnosis.. BMJ. 289(6453). 1171–1175. 98 indexed citations
11.
Hanson, Ulf, Lars Hagenfeldt, & Kerstin Hagenfeldt. (1983). Glycosylated hemoglobins in normal pregnancy: sequential changes and relation to birth weight.. PubMed. 62(6). 741–4. 22 indexed citations
12.
Eriksson, L. S., David Law, Lars Hagenfeldt, & John Wahren. (1983). Nitrogen Metabolism of the Human Brain. Journal of Neurochemistry. 41(5). 1324–1328. 13 indexed citations
13.
Eriksson, S., Lars Hagenfeldt, David Law, et al.. (1983). Effect of prostaglandin synthesis inhibitors on basal and carbon dioxide stimulated cerebral blood flow in man. Acta Physiologica Scandinavica. 117(2). 203–211. 67 indexed citations
14.
Wennmalm, A, et al.. (1983). Effect of prostaglandin synthesis inhibitors on basal and carbon dioxide-stimulated cerebral blood flow in man.. PubMed. 12. 351–5. 10 indexed citations
15.
16.
Hagenfeldt, Lars, et al.. (1978). [Treatment of hepatic coma with balanced amino acid solution].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 75(50). 4707–10. 1 indexed citations
17.
Hagenfeldt, Lars, et al.. (1977). Muscle Metabolism during Exercise in Hemiparetic Patients. Clinical Science. 53(3). 257–269. 81 indexed citations
18.
Hagenfeldt, Lars & John Wahren. (1975). Turnover of plasma-free arachidonic and oleic acids in resting and exercising human subjects. Metabolism. 24(7). 799–806. 19 indexed citations
19.
Groth, C. G., Sten Dreborg, P.A. Öckerman, et al.. (1971). SPLENIC TRANSPLANTATION IN A CASE OF GAUCHER'S DISEASE. The Lancet. 297(7712). 1260–1264. 40 indexed citations
20.
Hagenfeldt, Lars, et al.. (1971). BLOOD INORGANIC PHOSPHATE, PYRUVATE AND LACTATE DURING AN INTRAVENOUS GLUCOSE TOLERANCE TEST IN ISCHEMIC CARDIOVASCULAR DISEASE. Acta Medica Scandinavica. 189(1-6). 207–211. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026